Skip To Content

ACD/Labs Blog

Sanji Bhal
In 2017 we conducted our first formal customer service oriented survey. Completed by 482 industry professionals working in pharmaceuticals, academia, agrosciences, life science, and chemicals and materials science, our survey explored satisfaction with ACD/Labs’ support, responsiveness, employee knowledge, and overall software quality. A summary of the results is presented here.

Sherry Myles
Software solution provides deeper understanding of new chemicals and their impact on the environment Toronto, CANADA (January 12, 2016)—ACD/Labs, a Toronto-based chemistry software company, today announced that for the past three years professor Raphael Terreux of the University of Lyon has relied on the ACD/Percepta Platform for a collaborative research project investigating new, environmentally friendly...

Sherry Myles
ADME/Tox and PhysChem predictions on the Percepta Platform will help educate and train the next generation of pharmaceutical scientists. Toronto, Canada (16, December, 2013)—The Université Paris-Sud (France), School of Pharmacy, has selected ACD/Labs’ ADME, Toxicity, and PhysChem predictors on the ACD/Percepta Platform, to enable in silico evaluation of pharmaceutical substances and research compounds. The software...

Sherry Myles
Reliable in-silico prediction tools for physicochemical properties, ADME characteristics, toxicity endpoints, structure design, and optimization, in one seamless software platform. Toronto, Canada (October 24, 2011)—ACD/Labs is pleased to announce the release of ACD/Labs Percepta, an advanced software platform for accurate in silico ADME/Tox and physicochemical property prediction, at AAPS 2011. The next generation of ACD/Labs...

Arvin Moser
In this final installment of the series on Drug Development, we examine stage 4 and the effort involved in Drug Manufacturing and Process. The 4th stage begins with a large scale production of the new drug, followed by formulation studies and then ending with regulatory reviews of the entire process before the drug can be...

Arvin Moser
The main focus surrounding the Drug Design stage (see diagram in Part 1) is to optimize the hit compound(s) and produce analogues that will increase the activity at the target site. Lead optimization is accomplished through minor modifications of the hit compound. In Drug Design, medicinal chemists aim to build a diverse library of compounds...

Arvin Moser
Many new medicinal drugs produced by pharmaceutical companies follow a very similar pathway starting from the inception of the project idea and ending at the shelves of a pharmacy. Each stage in the development of the drug involves various types of chemists, each lending their expertise at synthesizing, extracting, analyzing and testing the new drug....